Zipthro-500

• Excellent patient compliance with 3-day once daily dosing
• Broad spectrum of activity against Gram+ve, Gram+ve & typical pathogens
• Rapidly pentrates phagocytic cells, with the release at local sites of infection
• Maintains sustained pulmonary tissue concentrations higher than MICs for major Respiratory Pathogens
• 3-day regimen of azithromycin is as effective as a 10-day regimen of co-amoxiclav in the treatment of acute lower respiratory tract infections

Genitourinary Tract Infections

Community Acquired Pneumonia

Infected Dermatitis/Tonsilitis/Sinusitis

Acute Bacterial Exacerbations of Chronic Bronchitis